زينيكوين 50 مجم أقراص مغلفة للكلاب والقطط
Zeniquin (marbofloxacin) 50 mg is a synthetic, broad-spectrum fluoroquinolone antibacterial film-coated tablet for dogs and cats. Indicated for the treatment of infectious diseases associated with bacteria susceptible to marbofloxacin, particularly skin, soft tissue, and urinary tract infections.
Dosage Form
N/A
Product Type
Pharmaceutical
Manufacturer
Package
Bottles of 100 or 250 scored film-coated tablets
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 2.75 to 5.5 mg/kg (1.25 to 2.5 mg/lb) body weight orally once daily (one 50 mg tablet per 9 to 18 kg) | Oral tablet | Continue treatment for 2 to 3 days beyond cessation of clinical signs, up to 30 days |
| Cat | 2.75 to 5.5 mg/kg (1.25 to 2.5 mg/lb) body weight orally once daily | Oral tablet | Continue treatment for 2 to 3 days after resolution, maximum 30 days |
No withdrawal information available.
Treatment of skin and soft tissue infections (wounds, abscesses, cellulitis, superficial and deep pyoderma) caused by susceptible strains of Staphylococcus pseudintermedius, E. coli, Proteus mirabilis.
Treatment of urinary tract infections (cystitis) in dogs and cats caused by susceptible strains of E. coli and Proteus mirabilis.
Do not use in immature, growing dogs: small/medium breeds under 8 months; large breeds under 12 months; giant breeds under 18 months, due to potential cartilage erosion.
Do not use in animals with known hypersensitivity to fluoroquinolones.
Quinolones may cause CNS stimulation; use with caution in animals with diagnosed or suspected seizure disorders.
Mild and transient inappetence, vomiting, lethargy, or loose stools.
Zeniquin 50 mg Film-Coated Tablets Prescribing Information
Leaflet50 mg/tablet
No diseases linked.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.